Abatacept treatment reduces disease activity in early primary Sjögren's syndrome (open-label proof of concept ASAP study). (Q48088375)
Jump to navigation
Jump to search
scientific article published on 28 January 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Abatacept treatment reduces disease activity in early primary Sjögren's syndrome (open-label proof of concept ASAP study). |
scientific article published on 28 January 2014 |
Statements
1 reference
Abatacept treatment reduces disease activity in early primary Sjögren's syndrome (open-label proof of concept ASAP study). (English)
1 reference
P M Meiners
1 reference
A Vissink
1 reference
F G M Kroese
1 reference
F K L Spijkervet
1 reference
N Sillevis Smitt-Kamminga
1 reference
W H Abdulahad
1 reference
J Bulthuis-Kuiper
1 reference
E Brouwer
1 reference
S Arends
1 reference
H Bootsma
1 reference
28 January 2014
1 reference
73
1 reference
7
1 reference
1393-1396
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference